Medicamen Biotech Limited

NSE MEDICAMEQ.NS

Medicamen Biotech Limited Shares (Diluted, Weighted) for the year ending March 31, 2024: 12,659,277

Medicamen Biotech Limited Shares (Diluted, Weighted) is 12,659,277 for the year ending March 31, 2024, a 1.63% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Medicamen Biotech Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 12,455,873, a 1.96% change year over year.
Medicamen Biotech Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 12,216,600, a 0.00% change year over year.
Medicamen Biotech Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 12,216,600, a 0.00% change year over year.
Medicamen Biotech Limited Shares (Diluted, Weighted) for the year ending March 31, 2020 was 12,216,600, a 4.43% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NSE: MEDICAMEQ.NS

Medicamen Biotech Limited

CEO	Mr. Rajesh Madan B. Pharma
IPO Date	Oct. 27, 2021
Location	India
Headquarters	1506, Chiranjiv Tower
Employees	378
Sector	Consumers Staples
Industries Personal Care Cleaning Supplies Cosmetics Dental Care Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Pharmaceuticals

Description

Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.

Key trends

Past 5 years